Back to Market Feed

This NDC is on FDA's drug shortage list (posted Oct 12, 2022)

Product Information

DEXTROAMP-AMPHETAMINE 5 MG TAB is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.2611 per EA under NDC 11534019001. Its NADAC has been published 317 times since Sep 9, 2020.

FDA first approved this application on Dec 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1

NDC

11534019001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209799

FDA Approved

12/28/2017

TE Code

AB

On Market Since

7/4/2018

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has been published 317 times since Sep 9, 2020, and over the history we have for it it has declined 21.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2611 per EA
All-time high$0.3720 (Apr 14, 2021)
All-time low$0.1824 (Jul 17, 2024)
52-week high$0.2661
52-week low$0.2386
Median price$0.2595
Average price$0.2635
Largest weekly change+37.0% (Aug 21, 2024)
Weeks tracked317
Tracking sinceSep 9, 2020

Price History

1W

0.0%

1M

-1.1%

3M

-0.5%

6M

+9.4%

1Y

+0.4%

3Y

-18.2%

5Y

-17.5%

All

-21.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BACK-BODY PAIN 500-32.5 MG CPLT
Generic
70000012702•Cardinal Health
$0.0422
per EA
EXTRA PAIN RELIEF CAPLET
Generic
49483037000•Time-Cap Labs Inc.
$0.0621
per EA
TENSION HEADACHE CAPLET
Generic
70000015901•Cardinal Health
$0.0622
per EA
TENSION HEADACHE CAPLET
Generic
70000015902•Cardinal Health
$0.0622
per EA
QC HEADACHE RELIEF TABLET
Generic
63868048501•Chain Drug Marketing Association
$0.0629
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037462•L. Perrigo Company
$0.0648
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037478•L. Perrigo Company
$0.0648
per EA
PAIN RELIEVER PLS 250-250-65 MG
Generic
00536132601•Rugby Laboratories
$0.0648
per EA
MIGRAINE 250-250-65 MG CPLT
Generic
24385036571•AmerisourceBergen
$0.0648
per EA
MIGRAINE FORMULA CAPLET
Generic
24385036578•AmerisourceBergen
$0.0648
per EA

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Manufacturer

Sunrise Pharmaceutical Inc. manufacturer profile

See the full portfolio, pricing trend, and other products from this labeler.

Drug market

dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate market comparison

Compare this molecule across participating manufacturers and inspect the broader market price spread.

Therapeutic class

Central Nervous System Stimulant class view

See how this drug behaves alongside other products in the same FDA pharmacologic class.

Trend hub

Latest market trends

Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.

Guide

Understanding NADAC pricing

Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMINE 5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMINE 5 MG TAB, manufactured by Sunrise Pharmaceutical Inc., is $0.2611 per EA (NDC 11534019001), effective Sep 30, 2026.

How has the price of DEXTROAMP-AMPHETAMINE 5 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has declined 21.2%. It has been tracked across 317 weekly CMS publications since Sep 9, 2020.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMINE 5 MG TAB?

Since Sep 9, 2020, the NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has ranged from a low of $0.1824 (Jul 17, 2024) to a high of $0.3720 (Apr 14, 2021), with a median of $0.2595 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMINE 5 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAMINE 5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DEXTROAMP-AMPHETAMINE 5 MG TAB?

DEXTROAMP-AMPHETAMINE 5 MG TAB (NDC 11534019001) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.

Is DEXTROAMP-AMPHETAMINE 5 MG TAB in shortage?

Yes — NDC 11534019001 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).